1 INTRODUCTION
Regional anesthetic blocks have become increasingly popular in pediatric surgery over the course of the last few decades. A large variety of peripheral and central nerve blocks have been studied and validated as analgesic adjuncts in an effort to decrease the neurotoxicity associated with general anesthesia in children and reduce the amount of both general anesthesia and opioids required. Recent studies have shown that nearly one‐quarter of anesthetic procedures performed on children worldwide now involve regional anesthesia[
1]. Caudal blocks (CB) are one of the most commonly administered regional blocks in pediatric patients undergoing infraumbilical surgery, accounting for 34%–40% of regional anesthetic blocks in children[
1,
2]. During a CB, a needle is passed through the sacrococcygeal ligament into the caudal space and local anesthetic, most often either bupivacaine or ropivacaine, is then delivered, sometimes in conjunction with other adjuvant medications[
3,
4]. Meredith Campbell, a urologist, first described CB in 1933 in relation to pediatric urologic surgery[
5]. Veyckemans et al. later described a single institution's experience performing 1100 CB between 1986 and 1989 and found that CB is a reliable, effective method of administering regional anesthesia with an analgesic success rate greater than 99% and a relatively short learning curve[
6]. Schuepfer et al. evaluated the learning curve for CB and found that seven anesthesiology residents required an average of just 32 CB each to achieve a success rate of 80%, comparable to their attending pediatric anesthesiologists, reinforcing the relative ease with which the procedure can be learned by beginners[
7]. Some of the most common indications for CB today include inguinal surgery and penile surgery, such as hypospadias repair[
4].
Within the last 35 years since Veyckemans and colleagues published their institution's experience, a host of articles have been published demonstrating the efficacy of CB in pediatric surgery, most often in the context of pediatric urologic surgery. A randomized controlled trial of 60 pediatric patients undergoing inguinal hernia repair showed that, when compared to general anesthesia alone, general anesthesia combined with CB led to decreased pain, greater intraoperative hemodynamic stability, and a significantly repressed neuroendocrine stress response to surgery, with lower serum glucose and cortisol concentrations[
8]. Aside from its obvious analgesic properties, CB in the pediatric population has been shown to be associated with both decreased postoperative agitation and decreased time spent in the postanesthesia care unit (PACU) [
9,
10]. Several studies have shown that complication rates directly related to CB administration are exceedingly low, often ranging from 0% to 3%, and very rarely serious[
1–
3]. CB has similarly been shown to not be associated with any increased incidence of postoperative complications as well[
11–
14].
Despite the abundance of data to support the widespread use of CB in pediatric surgery, there still exists some debate about when to administer the block in relation to the surgical procedure. Two studies in the 1990s examined postoperative pain outcomes in pediatric patients based on whether they received a CB prior to the surgery or immediately postoperatively. Rice et al. conducted a randomized, double‐blinded study of 40 children. Patients were randomized to receive a CB either immediately after induction of anesthesia or immediately after the surgery was completed, prior to emergence. Postoperative pain scores were assessed with an objective pain scale. The study found no significant difference between the two group in regards to postoperative pain scores, the need for postoperative analgesics, or time spent in PACU[
15]. Holthusen et al. conducted a similarly designed randomized, double‐blinded study of 25 children undergoing circumcision, with the children randomized to similar groups. He found no significant difference between the two groups in cumulative postoperative analgesic requirement within the first 48 h postoperatively or in time to initial analgesic administration. However, the postoperative CB group was shown to have decreased cumulative pain scores for the first 8 h postoperatively[
16].
Unlike this study, these prior studies did not also examine the intraoperative analgesic or opioid requirements of these patients. Provided that the timing of a CB does not appear to significantly affect the degree of postoperative pain, we set out in this study to determine if the timing of a CB instead affects the cumulative dose of opioids a pediatric patient receives, both intraoperatively and postoperatively. We hypothesized that preoperative CB would lead to decreased cumulative administration of intraoperative and postoperative opioids.
2 METHODS
We conducted a retrospective review of all male pediatric patients, aged 6 months to 36 months, undergoing one of a selection of various pediatric urologic procedures under the care of one of two attending pediatric anesthesiologists at a single institution between January 2019 and January 2023. Female patients were not intentionally excluded from this study; the observed lack of representation was simply due to the penoscrotal nature of most of these cases. Surgical procedures included hypospadias repair, chordee repair, inguinal hernia repair, circumcision, and orchiopexy, as shown in Table 1. One of the pediatric anesthesiologists routinely performs CB preoperatively following induction while the other routinely performs CB postoperatively just prior to emergence. CB were administered with either bupivacaine or ropivacaine. In PACU following conclusion of the case, patients routinely receive acetaminophen and/or ibuprofen if they are experiencing some degree of obvious pain and/or agitation. In a stepwise fashion, patients then sometimes receive opioids for additional analgesia if the initial medications are not helpful in relieving the pain/agitation. Selection of specific opioid was similar between the two groups. Extensive patient and procedure data were collected on demographic information, CB agent and dosage, intravenous (IV) and non‐IV non‐steroidal anti‐inflammatory drugs (NSAIDs) administration and dosage, opioid administration, agent and dosage, total surgical time (i.e., time from induction to emergence as documented in the electronic medical record), and total time in PACU. Patients were categorized based on whether they received a preoperative CB or postoperative CB. Potential confounders include the use of adjunct analgesics. Statistical analyses were conducted using the Mann–Whitney U‐test or the chi‐square test, as deemed appropriate. Analyses were performed in Python using the Pandas and NumPy libraries. A result was considered statistically significant at p < 0.05. The owner of the dataset referenced herein is the authors' own institution.
3 RESULTS
41 patients met inclusion criteria. Of these 41 patients, 24 received preoperative CB and 17 received postoperative CB. There was no significant difference between the two groups in regards to mean age (p = 0.481), weight (p = 0.842), CB dose (p = 0.750), total anesthesia time (p = 0.131), procedure duration (p = 0.057), or time spent in PACU (p = 0.701). Table 2 summarizes these results. Additionally, there was no significant difference between the two groups in regard to CB dose (p = 0.782) or CB weight‐based dose (p = 0.425). However, all patients (17/17) in the postoperative (post‐op) CB group received bupivacaine 0.25% while most (22/24) patients in the preoperative (pre‐op) CB group received ropivacaine 0.25%, as demonstrated in Table 3. No patients experienced any complications related to the delivery of the CB.
3/24 patients in the preoperative CB group received an acetaminophen suppository in comparison to 15/17 patients in the postoperative group. Despite both groups receiving adjunct IV analgesics (pre‐op CB 15/17 and post‐op CB 22/24), the analgesic of choice routinely differed: the preoperative CB group was more likely to receive IV acetaminophen (21/24), while the postoperative CB group was more likely to receive IV ketorolac (15/17) (p < 0.001). As a result, there was a statistically significant difference in the mean dose and weight‐based dose for IV acetaminophen and ketorolac across both groups, as shown in Table 4.
The groups differed in the cumulative amount of opioids received for analgesia. The preoperative CB group received a significantly smaller mean total opioid dose (i.e., cumulative intraoperative and postoperative opioid dose; 3.875 vs. 26.470 mcg, p < 0.001) and mean weight‐based opioid dose (0.360 vs. 2.620 mcg/kg, p < 0.001). The percentage of patients who received any opioids either intraoperatively or postoperatively was also significantly lower in the preoperative CB group (37.5% vs. 94.1%, p < 0.001), as seen in Table 2. Pain scores were determined subjectively by PACU nursing.
4 DISCUSSION
In this study, the group of pediatric male patients undergoing pediatric urologic procedures that received preoperative CB received less opioids for sufficient analgesia both intraoperatively and postoperatively when compared to the group that received postoperative CB. While the ideal timing of CB is still somewhat open for debate, it is abundantly clear within the current available literature that CB decreases the need for additional adjunct analgesic medications within pediatric surgery. In 2018, Alizadeh et al. demonstrated that CB was associated with decreased intraoperative fentanyl requirement during hypospadias repair[
17]. A similarly designed, earlier randomized study by Tobias et al. found that, when compared to postoperative infiltration of local anesthetic into the incisional site, CB was associated with both decreased isoflurane requirements intraoperatively and decreased opioid requirements postoperatively for analgesia[
18]. Additional randomized studies have only served to validate these findings; CB has been shown in other pediatric patient populations to lead to decreased propofol use, decreased opioid use, and decreased sevoflurane use[
19–
21]. And, though two prior studies compared the efficacy of preoperative CB and postoperative CB in pediatric patients in relation to postoperative pain scores and postoperative analgesic use, they did not account for potential differences in intraoperative analgesic use[
15,
16]. Thus, we believe this is the first study to look at the comparative efficacy of preoperative CB and postoperative CB in pediatric patients in regards to cumulative opioid dose received both intraoperatively and postoperatively.
This has potentially huge ramifications in pediatric surgery, as opioids in general are known to have the potential to produce long‐lasting neuropsychological effects in the pediatric population, such as decreased visuo‐constructional ability as a measure of higher‐order executive function, though this is often an effect of prolonged, repeat exposure to opioids[
22]. Still, based on the data within this study, the potential long‐term risks posed by opioid use in the pediatric population, and the overall efficacy and safety profile of CB in general, our findings suggest that preoperative CB should be administered in most cases—barring any contraindications—prior to infraumbilical surgery in the pediatric population in an effort to further decrease the utilization of intraoperative and postoperative opioids.
There are several limitations of this study. Perhaps most notably, a small patient population was evaluated. Despite the small patient population, though, a statistically significant difference was observed between the two groups in opioid use. The inclusion of only two pediatric anesthesiologists—each with a fixed routine of either preoperative or postoperative administration—represents a potential confounding variable, as differences in opioid use may reflect individual preferences in practice rather than timing of the CB alone. Future studies should include multiple practitioners performing both types of blocks to better isolate the timing effect. Furthermore, one might argue that the difference in opioid requirements may be because the postoperatively administered CBs may not have had sufficient time to exert their effects before patients began experiencing pain in the PACU, which could have prompted early opioid administration. However, since all opioids and IV NSAIDs were administered intraoperatively, this possible explanation has a very low probability. Furthermore, this was a single‐center, nonrandomized, retrospective analysis and is therefore subject to the potential biases that may introduce and the inherent limitations associated with such a study, including its potentially limited external validity.
5 CONCLUSIONS
In this study, preoperative CB was associated with a significantly decreased opioid requirement compared to postoperative CB in pediatric male patients undergoing urologic surgery. Our findings suggest that preoperative CB should be routinely favored over postoperative CB in an effort to minimize opioid use in male patients undergoing pediatric urologic surgery. Additional, randomized studies with strict parameters regarding the indications for opioid/analgesic administration are warranted to best evaluate the optimal timing of CB administration in this setting.
2026 The Author(s). UroPrecision published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.